Observational studyDiabetes, obesity & metabolism2026

SGLT2 Inhibitors and Cardiovascular Outcomes in Patients With Fabry Disease: Observations From a Federated Research Network.

Leandra Serio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.